MedPath

Universidad del Desarrollo

Universidad del Desarrollo logo
🇨🇱Chile
Ownership
Private
Established
1990-01-01
Employees
-
Market Cap
-
Website
http://www.udd.cl

Clinical Trials

20

Active:0
Completed:10

Trial Phases

3 Phases

Phase 2:3
Phase 4:5
Not Applicable:9

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials

Not Applicable
9 (52.9%)
Phase 4
5 (29.4%)
Phase 2
3 (17.6%)

Decreasing the Stigma of Mental Illness Among Health Science Students Through a Mentoring Program

Not Applicable
Not yet recruiting
Conditions
Social Stigma
First Posted Date
2024-09-12
Last Posted Date
2024-09-19
Lead Sponsor
Universidad del Desarrollo
Target Recruit Count
102
Registration Number
NCT06593171

Re-evaluation of the Effect Site Model of the PKPD Propofol Eleveld Model

Phase 4
Recruiting
Conditions
Surgery
Healthy
Interventions
Drug: fixed propofol infusion 15 mg/kg/h until 1% BSR (burst suppression ratio)
First Posted Date
2024-05-16
Last Posted Date
2024-05-16
Lead Sponsor
Universidad del Desarrollo
Target Recruit Count
24
Registration Number
NCT06417645
Locations
🇨🇱

Hospital Base san José de Osorno, Osorno, Chile

Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation

Not Applicable
Recruiting
Conditions
Hematologic Cancer
First Posted Date
2024-02-15
Last Posted Date
2024-07-11
Lead Sponsor
Universidad del Desarrollo
Target Recruit Count
30
Registration Number
NCT06260111
Locations
🇨🇱

Clinica Dávila, Santiago, Metropolitana, Chile

Workplace Intervention to Reduce Sitting Time: a Randomized Clinical Trial.

Not Applicable
Completed
Conditions
Sedentary Behavior
Office Workers
First Posted Date
2023-03-30
Last Posted Date
2025-05-15
Lead Sponsor
Universidad del Desarrollo
Target Recruit Count
106
Registration Number
NCT05790837
Locations
🇨🇱

Universidad Autónoma de Chile, Santiago, Chile

Evaluation of the EEG Connectivity Using Predominant Dexmedetomidine as Anesthetic in Fragile Brains

Conditions
Aging Problems
Interventions
Drug: Comparison MoCA test and EEG connectivity pre, intra and postoperative between groups P vs D-P
First Posted Date
2022-06-21
Last Posted Date
2022-06-21
Lead Sponsor
Universidad del Desarrollo
Target Recruit Count
24
Registration Number
NCT05425069
Locations
🇨🇱

Hospital Base San Jose, Osorno, Los Lagos, Chile

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.